Alcon
Alcon manufactures intraocular lenses, which replace the natural lens removed during cataract surgery. It is the second largest division of Swiss group Novartis.
Alcon operates in more than 75 countries, serving 180 markets and employing more than 24,000 people. The Cork centre manufactures AcrySof® intraocular lenses, the most frequently implanted lenses worldwide.
Technologies and processes featured at the Cork site include mould-tool manufacturing, monomer formulation, casting, curing/polymerization, high precision optical measurement and packaging. Approximately 400 employees work at the site.
Financial Data
-
31st Dec 17 Source: CRO
- €46.4 million turnover
-
€1.5 million
profit - 404 employees
-
31st Dec 16 Source: CRO
- €40.9 million turnover
-
€2.6 million
profit - 394 employees
- 4 more years available »
Ranking
By Turnover
(€46.4 million)- 710th in Top Companies
- 73rd in Pharma
By Employees
(404)- 407th in Top Companies
- 40th in Pharma
- 404
- €46.4 million
Employees
- Jackie Murphy Country Manager
Latest News
- 8:59am Pub group Mitchells & Butlers profit rises on food and drink sales
- 8:09am Kerry co-op to raise €90m from sale of Kerry Group shares
- 7:28am Prolonged unseasonal weather pushes Origin Enterprises sales down
- 7:02am Alibaba to raise up to $12.9 bn in Hong Kong share sale
- 6:51am Aston Martin launches €170,000 SUV, hopeful of a turnaround